News

March 2, 2017

Application for FDA Approval of Alimta Injection for Mesothelioma, Lung Cancer Accepted for Review

News

The U.S. Food and Drug Administration (FDA) has accepted the filing of Eagle Pharmaceutical’s new drug application (NDA) for its novel ready-to-dilute Alimta (pemetrexed injection) chemotherapy drug for the treatment ... Read more

March 1, 2017

High Temperature Platinol Shows Promise in Treating Malignant Pleural Effusion

News

Injecting heated chemotherapy into the pleural cavity, the region between the two thin layers lining the lungs, is a promising approach for patients who present with malignant pleural effusion (MPE) — ... Read more

February 28, 2017

New Generation of CAR T-cells May Be Effective Against Mesothelioma

News

A new generation of CAR T-cell immunotherapy shows promising results in preclinical models of malignant mesothelioma, prompting researchers to suggest the treatment should be evaluated in clinical trials. In contrast to ... Read more

February 27, 2017

Victor Dahdaleh Foundation Officially Gives BLF £5M for Mesothelioma Research

News

A Feb. 23 signing ceremony at Great Britain’s House of Lords made the Victor Dahdaleh Foundation‘s recent £5 million ($6.2 million) donation to the British Lung Foundation (BLF) official. The ... Read more

February 24, 2017

Dovitinib Inhibitor Shows Minimal Activity in Treatment of MPM

News

Dovitinib seems to have only minimal activity in patients with malignant pleural mesothelioma (MPM) previously treated with chemotherapy. This is according to the results of a Phase 2 clinical trial ... Read more

February 23, 2017February 23, 2017

Immune Checkpoint Receptor Could Be Used to Develop MPM Treatment

News

The immune check-point receptor TIM-3 could be a promising new target in mesothelioma, suggests a study conducted by researcher in Belgium.

February 22, 2017

Outcome-prediction Tool Developed for Mesothelioma Patients with Relapses

News

Researchers have developed a three-factor tool to predict which malignant mesothelioma patients with relapses are likely to have better outcomes and which poorer outcomes. One benefit of the prognosis tool ... Read more

February 21, 2017

Long-term Chemo Improves Abdominal Mesothelioma Patients’ Survival Rates, Study Suggests

News

Long-term localized chemotherapy may significantly improve survival in patients with malignant peritoneal mesothelioma (MPM), according to a study. The research, “Long-Term Regional Chemotherapy For Patients With Epithelial Malignant Peritoneal Mesothelioma ... Read more

February 20, 2017

Family History of Melanoma Raises Risk for Mesothelioma, Other Cancers, Study Finds

News

Having first-degree relatives diagnosed with melanoma increases a person’s risk of pleural and peritoneal mesothelioma, a new study shows. Researchers believe that this is likely because the two cancers share common driver ... Read more

February 17, 2017February 17, 2017

Progression-Free Survival Not Valid Substitute for Overall Survival as Mesothelioma Measure, Study Says

News

Measures of progression-free survival cannot be used as substitute measures for overall survival in clinical trials of malignant mesothelioma, according to an analysis of data from 17 trials. The findings ... Read more